Drug–Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?

Concomitant administration of multiple drugs frequently causes severe pharmacokinetic or pharmacodynamic drug–drug interactions (DDIs) resulting in the possibility of enhanced toxicity and/or treatment failure. The activity of cytochrome P450 (CYP) 3A4 and P-glycoprotein (P-gp), a drug efflux pump s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdin, Venceslas, Bigot, William, Vanjak, Anthony, Burlacu, Ruxandra, Lopes, Amanda, Champion, Karine, Depond, Audrey, Amador-Borrero, Blanca, Sene, Damien, Comarmond, Chloe, Mouly, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672071/
https://www.ncbi.nlm.nih.gov/pubmed/38002732
http://dx.doi.org/10.3390/jcm12227120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672071/
https://www.ncbi.nlm.nih.gov/pubmed/38002732
http://dx.doi.org/10.3390/jcm12227120

Ejemplares similares